Vigiis101-LAB possesses strong tolerance to gastric acid and bile salts so there is no need for microencapsulation. Its concentration is up to more than 100 billion CFU/g and very low water activity (< 0.1) contributes to its high stability.
ANKASCIN 568-R is FREE of risky lovastatin/monacolin K but contains high levels of another two new active compounds (Monascin and Ankaflavin). Safety and functions have been verified through plenty of animal and clinical studies.
